It has been reported that GVHD can be divided into 3 subtypes based on the number of macrophages and T lymphocytes infiltrated in the skin, and that GVHD with many CD163+ macrophages was refractory with poor prognosis and a therapeutic challenge [5]. This evidence concerns the gene CD163 and graft versus host disease.